Prognostic impact of preoperative anemia on upper tract urothelial carcinoma.

Ping Tan,Nan Xie,Haotian Liao,Liqun Zou,Huan Xu,Lu Yang,Liangren Liu,Qiang Wei
DOI: https://doi.org/10.1097/MD.0000000000012300
IF: 1.6
2018-01-01
Medicine
Abstract:The aim of this study was to investigate the effect of preoperative anemia on the prognosis of patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). A total of 620 patients with UTUC were retrospectively analyzed. Anemia was decided by preoperatively measured hemoglobin values based on the World Health Organization (WHO) classification. Kaplan-Meier method and Cox proportional hazards regression models were used to analyze the relationship between anemia and survival outcomes. The meta-analysis part was performed according to PRISMA guidelines. The median follow-up was 51 (range: 1-168) months. A total of 246 patients had preoperative anemia in our cohort. Anemia was found to be related to high-grade (P<.001), sessile architecture (P=.001), advanced T stage (P<.001), lymphovascular invasion (LVI) (P=.006), and worse chronic kidney disease (CKD) stage (P=.012). Kaplan-Meier curves revealed that patients with preoperative anemia had worse overall survival (OS), cancer-specific survival (CSS), and disease recurrence-free survival (RFS) (all P<.001). Multivariable Cox analyses found that anemia was an independent predictor of CSS [ hazard ratio (HR) 1.719, 95% confidence interval (95% CI): 1.285-2.300], RFS (HR 1.427, 95% CI: 1.114-1.829) and OS (HR 1.756, 95% CI: 1.353-2.279). Among patients without end-stage renal disease (ESRD, n=614), the anemia was also proved to be associated with worse outcomes in multivariable Cox analysis (OS, HR 1.759, 95% CI: 1.353-2.287; CSS, HR 1.726, 95% CI: 1.289-2.311, and RFS, HR 1.431, 95% CI: 1.117-1.837). Seven studies were included in the meta-analysis, and the pooled results showed that anemia was also related to worse CSS (HR 2.05, 95% CI: 1.73-2.44), RFS (HR 1.57, 95% CI: 1.30-1.90), and OS (HR 1.53, 95% CI: 1.10-2.13), but not related to intravesical recurrence (HR 1.17, 95% CI: 0.75-1.82). Preoperative anemia was proved to be significantly associated with worse oncologic outcomes in patients with UTUC following RNU.
What problem does this paper attempt to address?